Eric Topol

Eric Topol

Creator
0 followers

Cardiologist and digital medicine researcher; leading voice on biotech and healthcare innovation.

Radiologists and AI Struggle to Spot Deepfake Scans
SocialMar 24, 2026

Radiologists and AI Struggle to Spot Deepfake Scans

The majority of radiologists and 4 LLMs were unable to differentiate synthetic, deepfake scans from real ones https://t.co/aAJhP0cpfG @RSNA https://t.co/q0wdIKicK6

By Eric Topol
Minor Lifestyle Tweaks Cut Major Heart Risks
SocialMar 23, 2026

Minor Lifestyle Tweaks Cut Major Heart Risks

Even small differences in sleep, physical activity and nutrition (SPAN) can have significant favorable impact vs major adverse cardiovascular events @uk_biobank, >53,000 participants, median age 63 yrs https://t.co/iZJjENsOiM https://t.co/WNiGfGGDYL

By Eric Topol
Thymus Gland Emerges as Key to Healthy Aging
SocialMar 23, 2026

Thymus Gland Emerges as Key to Healthy Aging

Don't take the time to read about the new landmark studies that put our thymus gland at center stage for healthy aging https://t.co/ENhIn2A2l3 https://t.co/oY2PLSenmf

By Eric Topol
Higher Thymic Health Scores Predict Longer Healthspan
SocialMar 22, 2026

Higher Thymic Health Scores Predict Longer Healthspan

Your Thymus and Your Healthspan https://t.co/ENhIn2A2l3 High vs Low Thymic Health Scores and Outcomes https://t.co/oOz9sOK8RV

By Eric Topol
Agentic AI Could Spark Billion-Mind Intelligence Explosion
SocialMar 21, 2026

Agentic AI Could Spark Billion-Mind Intelligence Explosion

"The recent explosion of agentic AI suggests the possibility of something similar at the scale of billions of interacting minds, human and non-human alike." An essay on the Intelligence Explosion @ScienceMagazine by @profjamesevans @bratton @blaiseaguera https://t.co/Fl0DP86XWd

By Eric Topol
Companies Hide Device Risks, Harm Thousands
SocialMar 20, 2026

Companies Hide Device Risks, Harm Thousands

This is a recurrent fiasco. Health care companies that now the serious risk of their device or drug but keep selling it and do not acknowledge the hazard. Until so many people are harmed. Today's front page @nytimes by @katie_thomas @bostonsci...

By Eric Topol
Higher Fitness Linked to Lower Dementia, Depression, Psychosis Risk
SocialMar 20, 2026

Higher Fitness Linked to Lower Dementia, Depression, Psychosis Risk

The relationship between increased cardiorespiratory fitness (METS) and reduced risk of all-cause dementia, depression, and psychotic disorders. From over 4 million individuals in 27 studies @NatMentHealth [association, not cause and effect evidence] https://t.co/iQdGRc0Nrz

By Eric Topol
Tumor Whole-Genome Sequencing Influences Care in 40%+ Patients
SocialMar 20, 2026

Tumor Whole-Genome Sequencing Influences Care in 40%+ Patients

Why should tumor whole genome sequencing (WGS) be done for cancer? In real practice of medicine study of 888 patients with solid cancers, WGS directly led to clinical consequences in over 40% @NatureMedicine https://t.co/kFho0yuLS7

By Eric Topol
AI Deciphers Life’s Language in New Nature Biotech Review
SocialMar 20, 2026

AI Deciphers Life’s Language in New Nature Biotech Review

AI to understand the language of life. Our review @NatureBiotech just published https://t.co/i0WMaXBCHl Free access https://t.co/3LPulNxlD0 @VishRao5 @serena2z @BrianPlosky @pdhsu @BoWang87 @james_y_zou @marinkazitnik @pranavrajpurkar

By Eric Topol
Hydration Doesn't Reduce Kidney Stone Recurrence, Study Finds
SocialMar 20, 2026

Hydration Doesn't Reduce Kidney Stone Recurrence, Study Finds

If you've had a kidney stone, you've been advised that the most important thing to prevent another bout is to increase hydration. Now a randomized trial of hydration in over 1600 participants showed no benefit, despite evidence of increase...

By Eric Topol
Stress Triggers Skin Inflammation via Newly Identified Neural Circuit
SocialMar 19, 2026

Stress Triggers Skin Inflammation via Newly Identified Neural Circuit

New @ScienceMagazine Discovery of a circuit that connects stress and skin inflammation https://t.co/Dkmmcs96JT https://t.co/chrXyKrG2N https://t.co/7nOPn9fCoU

By Eric Topol
Four Biomarkers Can Meaningfully Assess Coronary Artery Disease Risk
SocialMar 19, 2026

Four Biomarkers Can Meaningfully Assess Coronary Artery Disease Risk

The 4 biomarkers to meaningfully assess a person's risk of coronary artery disease @rayshafarah @aklfahed @pnatarajanmd @JACCJournals @uk_biobank https://t.co/CPfBPVRENq https://t.co/xTlj2ykr45

By Eric Topol
Oral Ozempic Trials Fail to Show Alzheimer's Benefit
SocialMar 19, 2026

Oral Ozempic Trials Fail to Show Alzheimer's Benefit

The negative oral Ozempic randomized trials (EVOKE, EVOKE+) for Alzheimer's disease have now been published @TheLancet https://t.co/Xx0YknTSC2

By Eric Topol
GLP‑1 Drugs May Protect Heart, Vessels, Kidneys in Type 1 Diabetes
SocialMar 19, 2026

GLP‑1 Drugs May Protect Heart, Vessels, Kidneys in Type 1 Diabetes

GLP-1 drugs have established benefit for Type 2 diabetes. New data suggests that extends to Type 1 diabetes, with heart, vascular, and kidney protection https://t.co/nZDKHoFIRm https://t.co/lTHIgoj4ir

By Eric Topol
Implant vs Meds: Randomized Trial Questions LAA Closure Benefit
SocialMar 18, 2026

Implant vs Meds: Randomized Trial Questions LAA Closure Benefit

Questioning the benefit of an implant to close the left atrial appendage vs medical therapy in a randomized trial @NEJM https://t.co/N0hpdIfmLe https://t.co/8bkk8FzLuY

By Eric Topol
Stopping GLP‑1 Therapy Quickly Erodes Cardiovascular Protection
SocialMar 18, 2026

Stopping GLP‑1 Therapy Quickly Erodes Cardiovascular Protection

A new finding after stopping GLP-1 drugs in a large cohort with Type 2 diabetes: rapid erosion of CV benefit/protection New @bmj_latest by @zalaly @Biostayan https://t.co/JG6yB8wTJJ See thread: https://t.co/6JvfIIjVBw https://t.co/wUgWhvs9Yy

By Eric Topol
In‑body Genome Editing Promises Cheaper, Practical CAR‑T Therapies
SocialMar 18, 2026

In‑body Genome Editing Promises Cheaper, Practical CAR‑T Therapies

What if we could engineer T cells in the body, making CAR T vs cancer, autoimmune diseases, and other applications far more practical, much less expensive? A step forward today via genome editing T cells https://t.co/FjgQA8NUlu https://t.co/XXk43WL1ac https://t.co/rpC7eCAlJH

By Eric Topol
Mitochondrial Transfer Shows Promise Against Parkinson’s in Animals
SocialMar 18, 2026

Mitochondrial Transfer Shows Promise Against Parkinson’s in Animals

Potential of mitochondrial transfer to prevent or treat Parkinson' s disease, in mouse and monkey models @CellCellPress https://t.co/c0oqfagddX https://t.co/KyBc1zQttc

By Eric Topol
World's Largest In‑Vivo CRISPR Data Engine Unveiled
SocialMar 17, 2026

World's Largest In‑Vivo CRISPR Data Engine Unveiled

From Prof Jin and my colleagues @scrippsresearch the largest in vivo CRISPR data engine, nearly 8 million cells, in collaboration with @nvidia and featured at GTC

By Eric Topol
GLP‑1 Weight Loss Shows No Extra Muscle Loss
SocialMar 17, 2026

GLP‑1 Weight Loss Shows No Extra Muscle Loss

A study asserts lack of disproportionate loss of muscle mass or strength cf weight loss from GLP-1 drug treatment, in mice and a small short term (12 weeks) trial in men The issue remains unsettled and counters the efforts by companies...

By Eric Topol
Single-Cell Analysis Advances Neurodegenerative Disease Understanding
SocialMar 17, 2026

Single-Cell Analysis Advances Neurodegenerative Disease Understanding

Neurodegenerative diseases at the single-cell level, a powerful tool to differentiate and better understand https://t.co/Pkz4qW0ELM @jclinicalinvest https://t.co/LiJ4FojRYZ

By Eric Topol
Women Comprise Two‑thirds of Alzheimer’s; Midlife Origins Examined
SocialMar 17, 2026

Women Comprise Two‑thirds of Alzheimer’s; Midlife Origins Examined

Why do women account for nearly 2/3rd of all cases of Alzheimer's disease? A new, thorough review @jclinicalinvest, open-access, on its origins in midlife. https://t.co/obITwhEiYG https://t.co/RXBffM9jKV

By Eric Topol
GenAI Predicts Insulin Resistance Using Wearables and Routine Labs
SocialMar 16, 2026

GenAI Predicts Insulin Resistance Using Wearables and Routine Labs

Innovation with genAI, predicting insulin resistance from wearable device data (for steps, heart rate, sleep) integrated with demographics and routine blood parameters. Without CGM. @aametwally1 @GoogleResearch @NatureMedicine https://t.co/PRZPLGjuxZ https://t.co/ShbFyO55qP

By Eric Topol
Multi-Ancestry Polygenic Score Predicts T2D, Obesity, GLP‑1 Need
SocialMar 16, 2026

Multi-Ancestry Polygenic Score Predicts T2D, Obesity, GLP‑1 Need

A polygenic risk score that predicts Type 2 diabetes, obesity, and likelihood for requiring a GLP-1 drug. Across 6 ancestries. https://t.co/5hTVv8kqlK https://t.co/IgXhx8vFA6

By Eric Topol
AI-Driven Digital Biology Delivers Custom Cancer Vaccine for Dog
SocialMar 16, 2026

AI-Driven Digital Biology Delivers Custom Cancer Vaccine for Dog

The era of digital biology, exemplified by making a bespoke and effective vaccine for cancer in a dog, is taking off. Access to the AI-Coscientist. A new feature @NatureMedicine https://t.co/AR9lqne7E1

By Eric Topol
Aged Blood Stem Cell Mutations Drive Aortic Aneurysm Growth
SocialMar 16, 2026

Aged Blood Stem Cell Mutations Drive Aortic Aneurysm Growth

Just weeks ago we didn't know that mutant clones of our aged blood stem cells could be linked to expansion of an aortic aneurysm. No less how. And so much more https://t.co/YuEmJPkdg2 https://t.co/qQq2dgAfWf

By Eric Topol
GLP‑1 Drugs: Promising yet Unproven Healthspan Extension
SocialMar 15, 2026

GLP‑1 Drugs: Promising yet Unproven Healthspan Extension

GLP-1 drugs for extending healthspan? Intriguing but we're a long way off from evidence Discussed at length in Super Agers as a candidate drug beyond lifestyle + factors @TheEconomist gift link https://t.co/A2dpfcnApF https://t.co/3gY8iACeGs

By Eric Topol
Dynamic Evaluation Framework for LLMs in Patient Care
SocialMar 15, 2026

Dynamic Evaluation Framework for LLMs in Patient Care

Our new @NatureMedicine paper proposing a path for better, dynamic evaluation of large language models for patient care https://t.co/VHvyxDFKuc CES-clinical environment simulator @pranavrajpurkar https://t.co/Q9tyeupEk3

By Eric Topol
Cancer Vaccines Show Promise for Hard-to-Treat Tumors
SocialMar 13, 2026

Cancer Vaccines Show Promise for Hard-to-Treat Tumors

Cancer vaccines are showing marked efficacy vs refractory cancers and are going to be part of the future Rx armamentarium. Beyond that, ultimately, for prevention in high-risk individuals. A new stellar review @NatureMedicine https://t.co/PhtdZDtSBl https://t.co/okmwCD8AyB

By Eric Topol
Amyloid Antibody Therapy Triggers 100 Microhemorrhages in APOE4 Patient
SocialMar 13, 2026

Amyloid Antibody Therapy Triggers 100 Microhemorrhages in APOE4 Patient

100 brain microhemorrhages in a patient with cerebral amyloid angiopathy and 2 copies of APOE4 after amyloid antibody therapy https://t.co/ASpVuijFNW https://t.co/hdtwtv1usq

By Eric Topol
HSV-1 Reactivation Linked to Faster Aging, Dementia
SocialMar 13, 2026

HSV-1 Reactivation Linked to Faster Aging, Dementia

The reactivation of herpes simplex virus (HSV-1, not only herpes zoster) may be tied to accelerated aging and dementia, and account in part for the mechanism of Shingrix vaccine''s protection @WIRED https://t.co/iKF1JcYSu0

By Eric Topol
Gut Microbiome Proteins Influence Aging Speed, Metabolic Disease
SocialMar 13, 2026

Gut Microbiome Proteins Influence Aging Speed, Metabolic Disease

Links between gut microbiome proteins and pace of aging, metabolic diseases, and medications @Cell_Metabolism https://t.co/Vg6vMPjnXm https://t.co/3SKNH6IEhJ

By Eric Topol
High‑fat Diet Pushes Gut Bacteria to Brain via Vagus
SocialMar 12, 2026

High‑fat Diet Pushes Gut Bacteria to Brain via Vagus

How to get bacteria to move from the gut into the brain? —eat a high-fat diet —vagus nerve is the conduit —in the mouse model https://t.co/BI6HIbVgPl

By Eric Topol
New Cancer Interception Strategy Regresses Pancreatic Precancers
SocialMar 12, 2026

New Cancer Interception Strategy Regresses Pancreatic Precancers

🆕 @ScienceMagazine An exciting new approach vs pancreatic cancer: "cancer interception" Considered ubiquitous, the pancreas in healthy adults has hundreds of PanINs of microscopic premalignant cancer that can be regressed in the experimental model https://t.co/erVtthSMjS https://t.co/2xHIYdIPrx

By Eric Topol
Microbes in Tumors: Unraveling a Controversial Role
SocialMar 12, 2026

Microbes in Tumors: Unraveling a Controversial Role

What is the significance of microbes in tumors, a field mired in controversy? https://t.co/D5sHkLLsrT https://t.co/ntGLlke4iC

By Eric Topol
RFK Jr Promotes Unproven Peptides, BPC‑157 Lacks Solid Data
SocialMar 12, 2026

RFK Jr Promotes Unproven Peptides, BPC‑157 Lacks Solid Data

RFK Jr is trying to get 14 peptides, without data on safety or efficacy, licensed and approved by FDA. His favorite is BPC-157. "Only three small human studies of BPC-157 exist, for instance, the largest of which is a telephone...

By Eric Topol
GenAI Health Tools Multiply: ChatGPT, Claude, CoPilot
SocialMar 12, 2026

GenAI Health Tools Multiply: ChatGPT, Claude, CoPilot

In January there was ChatGPT Health, Claude Health. Today there's Microsoft CoPilot Health. And more to come in the genAI -> health landscape https://t.co/TInH9YTvwA

By Eric Topol
LLMs Are Homogenizing Human Thought, Researchers Warn
SocialMar 11, 2026

LLMs Are Homogenizing Human Thought, Researchers Warn

In their paper today, the authors assert that LLMs are "homogenizing" human thought and expression https://t.co/HEaJyizbBL https://t.co/436zQieCKy

By Eric Topol
Gut Microbes Modulate Age‑related Memory and Cognition
SocialMar 11, 2026

Gut Microbes Modulate Age‑related Memory and Cognition

Gut microbes signal the brain influencing age-associated memory and cognitive function in the experimental model @arcinstitute @Nature https://t.co/elSw3RXbI9 https://t.co/6fRfCk4Z9n

By Eric Topol
GLP‑1 Drug Linked to Longer Survival in Brain Metastases
SocialMar 11, 2026

GLP‑1 Drug Linked to Longer Survival in Brain Metastases

Another potential GLP-1 drug benefit seen in people with diabetes and brain metastases for improved survival; a retrospective study that needs further assessment but intriguing https://t.co/nZm3xEYQMH https://t.co/V76S7o1MJb

By Eric Topol
Alzheimer’s Blood Markers Also Flag Certain Amyloidosis Types
SocialMar 11, 2026

Alzheimer’s Blood Markers Also Flag Certain Amyloidosis Types

The blood neuromarkers p-tau181 and p-tau217 that can predict and diagnose Alzheimer's disease are also abnormal in certain types of amyloidosis, indicating both some non-specificity and potential help in diagnosis of these conditions https://t.co/jodvMY6TNK

By Eric Topol
Severe COVID/Flu May Boost Lung Cancer Risk
SocialMar 11, 2026

Severe COVID/Flu May Boost Lung Cancer Risk

A causal link between severe Covid or flu and lung cancer risk by impairing immunity and promoting inflammation, as shown in multiple murine models https://t.co/NvE6uIYFZh

By Eric Topol
AI Augments, Not Replaces, Human Insight in Complex Biology
SocialMar 10, 2026

AI Augments, Not Replaces, Human Insight in Complex Biology

"AI will not replace biological reasoning, but it may become indispensable for navigating biological systems whose complexity exceeds human intuition." A perspective on future applications for cancer neuroscience https://t.co/TnDFZ7NRFN @scisignal https://t.co/ijbhfbjXcs

By Eric Topol
Doctors Still Beat AI on Practicality and Cost
SocialMar 10, 2026

Doctors Still Beat AI on Practicality and Cost

Comparison of AI and primary care physicians for 100 patients in a prospective real-world assessment —The physicians outperformed AI [AIME] for practicality and cost-effectiveness —AI was comparable for diagnosis, management plan, appropriateness and safety @AdamRodmanMD @alan_karthi @PeterBrodeurMD @googledeepmind https://t.co/FNWYoHVkkw

By Eric Topol
Blood Test Predicts Alzheimer's up to 25 Years Early
SocialMar 10, 2026

Blood Test Predicts Alzheimer's up to 25 Years Early

Predicting Alzheimer's disease up to 25 years in advance of any symptoms with the p-tau217 biomarker blood test, among 2,766 women mean age 70 https://t.co/aOActAUN27 https://t.co/Bxl2YZxnlf

By Eric Topol
AI Proven to Boost Breast Cancer Screening Accuracy
SocialMar 10, 2026

AI Proven to Boost Breast Cancer Screening Accuracy

3 new reports and an editorial @NatureCancer reinforce the benefit of AI for breast cancer screening https://t.co/MlFns7M0yB https://t.co/MF3fj0CuIE https://t.co/a436srKDaD https://t.co/1XTMIsAPfg

By Eric Topol
Plastic Chemical DEHP Linked to Higher Breast Cancer Risk
SocialMar 9, 2026

Plastic Chemical DEHP Linked to Higher Breast Cancer Risk

The link between exposure to DEHP and its metabolite MEHP, found in plastics, and risk of breast cancer in a 20-year prospective study https://t.co/wKEVlMxWHT https://t.co/j5NL5QfTBu

By Eric Topol
Psoriasis' Immune Activation Reduces Skin Cancer Risk
SocialMar 9, 2026

Psoriasis' Immune Activation Reduces Skin Cancer Risk

Chronic inflammation generally poses a higher risk of cancer, so why does psoriasis-like disease have a lower risk of skin cancer. Why? Sustained immune cell activation https://t.co/kcxUHC8Ahk https://t.co/igqNDv5mdj

By Eric Topol
Societal Issues Stall US Life Expectancy Growth
SocialMar 9, 2026

Societal Issues Stall US Life Expectancy Growth

Why hasn't life expectancy been increasing in the United States? It's complicated. "The fact that the United States is far from a leader in longevity and that it continues to fall further behind nearly all other high-income countries indicates that there are...

By Eric Topol